NO20050979L - Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase - Google Patents

Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase

Info

Publication number
NO20050979L
NO20050979L NO20050979A NO20050979A NO20050979L NO 20050979 L NO20050979 L NO 20050979L NO 20050979 A NO20050979 A NO 20050979A NO 20050979 A NO20050979 A NO 20050979A NO 20050979 L NO20050979 L NO 20050979L
Authority
NO
Norway
Prior art keywords
crcv
coronavirus
hemagglutinin
polymerase
esterase
Prior art date
Application number
NO20050979A
Other languages
English (en)
Other versions
NO20050979D0 (no
Inventor
John Brownlie
Victoria Jane Chalker
Kerstin Erles
Original Assignee
Royal Veterinary College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Veterinary College filed Critical Royal Veterinary College
Publication of NO20050979D0 publication Critical patent/NO20050979D0/no
Publication of NO20050979L publication Critical patent/NO20050979L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Glass Compositions (AREA)

Abstract

Sammendrag: Et caninus respiratorisk coronavirus (CRCV) som er tilstede i luftveiene hos hunder med caninus infeksiøs respiratorisk sykdom, og som har et lavt nivå av homologi med det enteriske caninus coronaviruset, men som har et høyt nivå av homologi med alle bovine coronavirus stammer (for eksempel Quebec og LY 138) og med humant coronavirus stamme OC43. CRCV-toppen, polymerase og hemagglutinin/esterase cDNA og protein partielle sekvenser er listet i figur (I) til (4), (13) og (14).
NO20050979A 2002-07-27 2005-02-23 Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase NO20050979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0217434.0A GB0217434D0 (en) 2002-07-27 2002-07-27 Biological material
PCT/GB2003/002832 WO2004011651A1 (en) 2002-07-27 2003-07-01 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase

Publications (2)

Publication Number Publication Date
NO20050979D0 NO20050979D0 (no) 2005-02-23
NO20050979L true NO20050979L (no) 2005-04-25

Family

ID=9941223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050979A NO20050979L (no) 2002-07-27 2005-02-23 Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase

Country Status (17)

Country Link
US (2) US7776340B2 (no)
EP (2) EP1525313B1 (no)
JP (1) JP4644486B2 (no)
AT (1) ATE491793T1 (no)
AU (1) AU2003244822B2 (no)
CA (2) CA2727782C (no)
CY (1) CY1111655T1 (no)
DE (1) DE60335374D1 (no)
DK (1) DK1525313T3 (no)
ES (1) ES2384445T3 (no)
GB (1) GB0217434D0 (no)
MX (1) MXPA05001098A (no)
NO (1) NO20050979L (no)
NZ (2) NZ556442A (no)
PT (1) PT1525313E (no)
SI (1) SI1525313T1 (no)
WO (1) WO2004011651A1 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
WO2004060278A2 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8057993B2 (en) * 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
WO2006076007A2 (en) * 2004-04-22 2006-07-20 Vanderbilt University Methods of detecting coronavirus infections
ES2641832T3 (es) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US20060205040A1 (en) 2005-03-03 2006-09-14 Rangarajan Sampath Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
EP1904655A2 (en) 2005-07-21 2008-04-02 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
NZ566490A (en) 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
EP2283859A3 (en) * 2005-10-26 2011-05-04 Canio Buonavoglia Pantropic canine coronavirus
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
AU2007353877B2 (en) 2006-09-14 2012-07-19 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
JP5680304B2 (ja) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド 迅速な法医学的ｄｎａ分析法
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
WO2010033627A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc IONIZATION PROBE ASSEMBLIES
EP2454000A4 (en) 2009-07-17 2016-08-10 Ibis Biosciences Inc SYSTEMS FOR IDENTIFYING BIOLOGICAL SUBSTANCES
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
EP2957641B1 (en) 2009-10-15 2017-05-17 Ibis Biosciences, Inc. Multiple displacement amplification
CN103596588B (zh) * 2011-02-04 2016-02-03 佐蒂斯有限责任公司 用于犬呼吸道疾病综合征的组合物
PT2670432T (pt) * 2011-02-04 2021-05-04 Zoetis Services Llc Composições imunogénicas de bordetella bronchiseptica
ITMI20111182A1 (it) * 2011-06-28 2012-12-29 Canio Buonavoglia Vaccino per coronavirus canino
EP2854847B1 (en) * 2012-05-31 2019-08-07 Zoetis Services LLC Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections
CN105803112A (zh) * 2016-03-28 2016-07-27 中国人民解放军成都军区疾病预防控制中心 用于检测犬细小病毒的引物、探针和试剂盒及检测方法
CN108318685A (zh) * 2018-05-04 2018-07-24 广州敏捷生物技术有限公司 用于检测犬冠状病毒抗原的免疫荧光层析检测卡与制备方法
CN111254155A (zh) * 2020-01-25 2020-06-09 王跃驹 一种植物作为宿主表达病毒疫苗的方法
EP4050035A4 (en) * 2020-02-10 2022-12-28 Institute of Microbiology of Chinese Academy of Science Beta-coronavirus antigen, preparation method therefor and use thereof
AU2021358538A1 (en) * 2020-10-08 2023-05-25 Controlpoint Inc. Methods and apparatuses for detecting respiratory infections
CN112094953B (zh) * 2020-10-30 2022-11-11 内蒙古农业大学 用于同时检测牛病毒性腹泻病毒、牛轮状病毒和牛冠状病毒的试剂盒及引物和探针
US11175293B1 (en) 2021-01-04 2021-11-16 University Of Utah Research Foundation Rapid assay for detection of SARS-CoV-2 antibodies
CA3106787A1 (en) * 2021-01-22 2022-07-22 Amphotericin B Technologies Inc. Use of amphotericin b in the treatment of coronavirus diseases
CN116375854A (zh) * 2023-04-18 2023-07-04 领地动物诊疗科技(厦门)有限公司 抗犬冠状病毒n蛋白抗体对及其制备方法、核酸分子、细胞株和应用
CN116854784B (zh) * 2023-09-05 2023-11-17 北京纳百生物科技有限公司 犬冠状病毒n蛋白抗原截短体及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6057436A (en) 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
ES2213743T3 (es) * 1991-04-25 2004-09-01 Akzo Nobel N.V. Vacuna de subunidad de coronavirus canino.
JP3245169B2 (ja) 1992-05-08 2002-01-07 ファイザー・インコーポレイテッド イヌ・コロナウイルスｓ遺伝子およびその使用
US5750112A (en) 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
DE69633233T2 (de) * 1995-06-12 2005-08-11 Kansas State University Research Foundation, Manhattan Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
CA2268007A1 (en) 1996-10-11 1998-04-23 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
WO1999025838A1 (en) 1997-11-14 1999-05-27 University Of Georgia Research Foundation, Inc. Compositions and methods to prevent turkey enteritis
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours

Also Published As

Publication number Publication date
DE60335374D1 (en) 2011-01-27
DK1525313T3 (da) 2011-03-14
US7776340B2 (en) 2010-08-17
EP2182066A2 (en) 2010-05-05
PT1525313E (pt) 2011-03-14
CY1111655T1 (el) 2015-10-07
CA2492333C (en) 2013-08-20
GB0217434D0 (en) 2002-09-04
AU2003244822A1 (en) 2004-02-16
US20090081780A1 (en) 2009-03-26
NZ537778A (en) 2008-04-30
JP2005533513A (ja) 2005-11-10
EP2182066A3 (en) 2010-08-11
EP1525313B1 (en) 2010-12-15
EP1525313A1 (en) 2005-04-27
CA2727782A1 (en) 2004-02-05
US20070248616A1 (en) 2007-10-25
JP4644486B2 (ja) 2011-03-02
ATE491793T1 (de) 2011-01-15
MXPA05001098A (es) 2005-09-08
ES2384445T3 (es) 2012-07-05
SI1525313T1 (sl) 2011-03-31
NO20050979D0 (no) 2005-02-23
WO2004011651A1 (en) 2004-02-05
AU2003244822B2 (en) 2009-01-29
CA2727782C (en) 2016-10-11
NZ556442A (en) 2009-03-31
CA2492333A1 (en) 2004-02-05
US7981427B2 (en) 2011-07-19

Similar Documents

Publication Publication Date Title
DK1525313T3 (da) Canine respiratorisk coronavirus (CRCV) spikeprotein, polymerase og hæmagglutinin/esterase
CY1109848T1 (el) Συστημα καταιονισμου/αναρροφησεως
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
NO20074412L (no) Bruddresistente administrasjonsformer med forsinket frigiving
BRPI0408807A (pt) sistema de fixação de fratura de osso com suporte de superfìcie articular e subcondral
WO2006110738A3 (en) Active compression screw system and method for using the same
CR8012A (es) Clavo endomedular destinado al tratamiento de fracturas de femur proximal
NZ707292A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
WO2007109767A3 (en) Bone anchor installer and method of use
WO2008118524A3 (en) Instrumented linkage system
DE502005008015D1 (de) Künstliches gelenkelement sowie ein damit ausgestattetes greifwerkzeug
ATE392859T1 (de) Wirbelsäulen-osteosynthesesystem
ATE518494T1 (de) Aufbau mit hydroxylierter oberfläche
DE602007001467D1 (de) Therapeutische Zubereitung von hochreinem FVIIa und Verfahren zu dessen Gewinnung
AU2003289631A8 (en) A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof
SE0201940D0 (sv) New combination II
CO6290611A2 (es) Clavo o tornillo de trasmision para asegurar una protesis al hueso y la instrumentacion y metodos asociados
ATE346552T1 (de) Implantatsystem
DE602004015772D1 (de) Ein matrizenband
WO2008029142A3 (en) A bone plate for fixation to a patient's vertebrae
SG160327A1 (en) Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
DE69835424D1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
MX2009003976A (es) Taladro para el uso en odontologia y con inercia modulada.
WO2003086453A8 (en) Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
DK1532279T3 (da) Fremgangsmåde, sammensætning og kit til antigenbinding af Norwalk-lignende vira

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application